Skip to main content
Skip to footer

Reinstating the Pharma Supply Chain Post COVID-19 Pandemic Disruptions

Mithugopal Mandal

Senior Management Consultant, Life Sciences Advisory Services, TCS

You have these already downloaded

We have sent you a copy of the report to your email again.

The crisis has triggered the need for approaches that companies can take to circumvent challenges and get their production back on track

Supply chain is the backbone of pharma manufacturing. Global disruptions from COVID-19 pandemic have severely impacted the supply chains. Unless the organizations plan effectively, there is a chance it may take longer to recover than expected. This whitepaper addresses the key areas the organizations need to focus on and take the quick action.

 

About the Author

Mithugopal Mandal
Mithugopal is a Senior Management Consultant in TCS’ Life Science Advisory Practice.
Read moreRead more Read more

Related reading

Life Sciences

Next-gen IT Testing: How TCS Helped Takeda Drive Quality at Speed

Case Studies | 15 Sep 2023
Life Sciences Vijaya Kumar Vishal Mhatre

Technology in Pharmaceutical Industry to Improve Efficiencies

White Paper | 31 Aug 2023
Life Sciences

BD Implements Digital eDHR Solution to Scale its Digital Manufacturing

video | 03 Aug 2023
Life Sciences Khushru Patel Shashibala Bhojani

Unified Technology Solution for Accelerating Clinical Development

White Paper | 29 Jun 2023

Transformation starts here

Integrated ecosystems are key to better patient outcomes.

Talk to our experts

Find out more